BioSig Technologies Inc. (NASDAQ:BSGM) Stock Falls 10% in a Week: Time to Buy?

BioSig Technologies Inc. (NASDAQ: BSGM) is down 10% in a week. The company is planning to host a conference call to discuss the conclusion of the PURE EP 2.0 study. The study had enrolled 51 subjects in Massachusetts General Hospital, Texas Cardiac Arrhythmia Institute located at St David’s Medical Centre, Austin, and Mayo Clinic Florida campus. The PURE EP device is meant to enhance procedural efficacy and efficiency in electrophysiology. So far, around 50 healthcare professionals have completed more than 1,000 cases using the device in 12 clinical sites.

The company announced the recent installation of its proprietary arrhythmia care medical tech platform at a hospital in New York.  BioSig installed the PURE EP technology at the New York Presbyterian Weill Cornell Medical Centre. The hospital started carrying patient cases using the system in June 2021, offering comprehensive electrophysiology in the country.

PURE EP System has FDA 510(k) approval, and the company commenced commercial sales last year. So, in the coming months, BSGM is a stock to watch.

Market Reaction:

On Monday, BSGM stock fell 2.60% at $3.78 with more than 302k shares, compared to its average volume of 349k shares. The stock had moved within a range of $ 3.7500 – 4.0300 after opening the trade at $3.86. Over the past 52-week, the stock has been trading within a range of $2.7900 – 9.7700.